Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer

Journal of Clinical Sleep Medicine

Volumn 4, Issue 5, 2008, Pages 441-449

  Palesh, Oxana ^a   Zeitzer, Jamie M ^b   Conrad, Ansgar ^b   Giese Davis, Janine ^b   Mustian, Karen M ^a   Popek, Varinia ^c   Nga, Karen ^b   Spiegel, David ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Breast cancer; Cortisol; RSA; Sleep disruption

Indexed keywords

HYDROCORTISONE;

ACTIMETRY; ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BREAST CANCER; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR CLINICAL STUDY; METASTASIS; NIGHT SLEEP; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP TIME; SLEEP WAKING CYCLE; SOCIAL STRESS; VAGUS TONE; WAKEFULNESS;

EID: 55349089609     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27280     Document Type: Article

References (63)

1. Malone M, Harris AL, Luscombe DK. Assessment of the impact of cancer on work, recreation, home management and sleep using a general health status measure. J R Soc Med 1994;87:386-9.
2. Kaye J, Kaye K, Madow L. Sleep patterns in patients with cancer and patients with cardiac disease. J Psychol 1983;114:107-13.
3. Koopman C, Nouriani B, Erickson V, et al. Sleep disturbances in women with metastatic breast cancer. Breast J 2002;8:362-70.
4. Palesh OG, Collie K, Batiuchok D, et al. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007;75:37-44.
5. Savard J, Morin CM. Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol 2001;19:895-908.
6. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 2001;24:583-90.
7. Berger A, Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 1999;26:1663-71.
8. Berger AM, Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum 2000;27:1443-8.
9. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998;16:1689-96.
10. Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 2000;14:275-90.
11. Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: A pilot study. J Pain Symptom Manage 1999;17:320-32.
12. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22:S386-S393
13. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-9.
14. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002;51:229-35.
15. Ohayon MM, Zulley J. Correlates of global sleep dissatisfaction in the German population. Sleep 2001;24:780-7.
16. Lee KA, Ward TM, Lee KA, Ward TM. Critical components of a sleep assessment for clinical practice settings. Issues Ment Health Nurs 2005;26:739-50.
17. Zee P, Walsleben J. Toward optimal health: The experts discuss sleep sufficiency and health. J Womens Health 2004;13:764-9.
18. Leger D, Guilleminault C, Bader G, Levy E, Paillard M, Levy E. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-9.
19. Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: Evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49-55.
20. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996;39:411-8.
21. Schwartz S, McDowell AW, Cole SR, Comoni-Huntley J, Hays JC, Blazer D. Insomnia and heart disease: A review of epidemiologic studies. J Psychosom Res 1999;47:313-33.
22. Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 2003;45:344-50.
23. Burgos I, Richter L, Klein T, et al. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study-Brain Behav Immun 2006;20:246-53.
24. Mander B, Colecchia E, Spiegel K, Van Cauter E. Short sleep: A risk factor for insulin resistance and obesity. Diabetes 2001;50:A45
25. Ryden AM, Knutson KL, Mander BA, Van Cauter E. Sleep in Type II diabetes: A survey study. Sleep 2002;25:A105-A106
26. Ryden AM, Knutson KL, Mander BA, Van Cauter EY. Association between sleep quality and glycemic control in type 2 diabetic African-American women. Diabetes 2002;51:A620
27. Janson C, Lindberg E, Gislason T, Elmasry A, Boman G. Insomnia in men-a 10-year prospective population based study. Sleep 2001;24:425-30.
28. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insornnia. Arch Gen Psychiatry 2002;59:131-6.
29. Pollak CP, Perlick D, Linsner JP, Wenston J, Hsieh F. Sleep problems in the community elderly as predictors of death and nursing home placement. J Community Health 1990;15:123-35.
30. Spiegel D, Sephton S. Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2002;94:530-3.
31. Anderson KO, Getto CJ, Mendoza TR, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 2003;25:307-18.
32. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 2002;24:471-80.
33. Mormont MC, Waterhouse J, Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000;6:3038-45.
34. Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety 2003;18:163-76.
35. Healey ES, Kales A, Monroe LJ, Bixler EO, Chamberlin K, Soldatos CR. Onset of insomnia: role of life-stress events. Psychosom Med 1981;43:439-51.
36. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med 2003;65:259-67.
37. Ford DE, Kamerow DB, Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-84.
38. Vgontzas AN, Bixler EO, Lin HM, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 2001;86:3787-94.
39. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J. Nocturnal cortisol release in relation to sleep structure. Sleep 1992;15:21-7.
40. Porges SW. Cardiac vagal tone: a physiological index of stress. Neurosci Biobehav Rev 1995;19:225-33.
41. Routledge HC, Chowdhary S, Townend JN. Heart rate variability - a therapeutic target? J Clin Pharm Ther 2002;27:85-92.
42. Rottenberg J, Clift A, Bolden S, Salomon K. RSA fluctuation in major depressive disorder. Psychophysiology 2007;44:450-8.
43. Irwin MR, Valladares EM, Motivala S, Thayer JF, Ehlers CL. Association between nocturnal vagal tone and sleep depth, sleep quality, and fatigue in alcohol dependence. Psychosom Med 2006;68:159-66.
44. El-Sheikh M, Buckbalt JA. Vagal regulation and emotional intensity predict children's sleep problems. Dev Psychobiol 2005;46:307-17.
45. Spiegel D, Giese-Davis J, Taylor CB, Kraemer H. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 2006;31:1231-44.
46. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003;26:342-92.
47. Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993;28:76-81.
48. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.
49. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151-69.
50. Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983;45:333-9.
51. Spiegel D, Bloom JR. Pain in metastatic breast cancer. Cancer 1983;52:341-5.
52. First MB, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Association, 1995.
53. Berntson GG, Bigger JT, Jr., Eckberg DL, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997;34:623-48.
54. Wilhelm FH, Grossman P, Coyle MA. Improving estimation of cardiac vagal tone during spontaneous breathing using a paced breathing calibration. Biomed Sci Instrum 2004;40:317-24.
55. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003;26:342-92.
56. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:994-1000.
57. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003;28:916-31.
58. Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004;29:1082-92.
59. Ticher A, Haus E, Ron IG, Sackett-Lundeen L, Ashkenazi IE. The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk. Int J Cancer 1996;65:591-3.
60. Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. Int J Cancer 1997;70:241-7.
61. Hobson JA. Sleep and dreaming. J Neurosci 1990;10:371-82.
62. Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med 1998;60:610-5.
63. Giese-Davis J, Wilhelm FH, Conrad A, et al. Depression and stress reactivity in metastatic breast cancer. Psychosom Med 2006;68:675-83.